Giuliana Grossi

Consultation aids can elevate communication around rheumatic and musculoskeletal disease, therefore promoting shared decision making between patients and clinicians.

Research presented at EULAR aims to enhance communication with a conversation aid so patients can address challenges they encounter as a result of rheumatic and musculoskeletal disease with a rheumatologist.

Two phase 3 studies, BE OPTIMAL and BE COMPLETE, evaluated bimekizumab in adults with active psoriatic arthritis who were biologic-naïve and TNF-inadequate responders.

Data from 2 studies evaluating adults with active psoriatic arthritis were announced today in preparation for EULAR 2022. The different population groups who received treatment were biologic-naive patients and TNF-inadequate responders.

Pri-Med West presenter, Dr. Peng Thim Fan asks the questions that many rheumatologists have likely been contemplating now that disease treatment is so successful.

While some physicians might initially assume that oral medications like upadacitinib aren't as effective as an injection, but Dr. Fan explains that's not the case.

Expert rheumatologist Dr. Peng Thim Fan explains that the effects of COVID-19 are still being examined.

ANCA-associated vasculitis may present like sinusitis, but it typically affects multiple organ systems.

Dr. Warrington discusses the details of glucocorticoids and how avacopan can help with the effective treatment of ANCA-associated vasculitis.

Infants born to mothers with autoimmune disease had a 16% higher risk of being diagnosed with a mental disorder compared with those who were not prenatally exposed to maternal autoimmune diseases.

Because vasculitis can manifest in various ways, Matthew Koster, MD, talks about identifying Granulomatosis with polyangiitis and other forms of the disease.

Tanaz Kermani, MD, MS, talks about the current state of vasculitis care and the latest research in the field.

Investigators address the need for understanding surrounding the relationship between poor bone health and patients who are hemophilia carriers and those with von Willebrand disease.

Patients with psoriatic arthritis and ankylosing spondylitis experienced rapid pain reduction with upadacitinib, regardless of treatment history.

From the struggle of obtaining insurance approvals to addressing the nationwide shortage of rheumatologists, Dr. Baker Frost talks about her experience treating patients with autoimmune disease.

Expert John Sergent shares insight on his best practices treating patients with autoimmune diseases.

In honor of Autoimmune Disease Awareness Month, expert Dr. Joe Ahearn and advocate Michael Linn discuss relapsing polychondritis.

Authors call for further investigation of pathophysiological pathways between rheumatoid arthritis and primary open-angle glaucoma.

Authors of the study on PRP in knee osteoarthritis addressed the concerns shared by physicians in response to the method of their research.

Because Sjögren's Syndrome is often undetected or misdiagnosed, investigators developed the Sjögren's Syndrome Screening Questionnaire (SSSQ).

Investigators in Israel perform the largest retrospective review of patients with rheumatic fever in a developed country, spanning 25 years of research.

The results lead investigators to question the usefulness of prehabilitation before total knee replacement to improve functional outcomes in patients with osteoarthritis.

ACR partners with the Vasculitis Foundation to establish a new guideline that addresses diagnostic issues relating to Kawasaki disease, a rare vasculitis that inflames the blood vessels.

Investigators examined the effect that pulsed low-intensity ultrasonography had on symptom relief and tibiofemoral articular cartilage thickness among patients with knee osteoarthritis.

The American College of Rheumatology releases 2 new guidelines for treating patients with juvenile idiopathic arthritis.

New recommendations were released by ACR and AAHKS regarding perioperative management of antirheumatic medications for patients with rheumatic diseases undergoing these procedures.

Expert John Sergent, MD, goes into detail about myositis and how to differentiate it from other inflammatory diseases.

These prominent leaders in the field of autoimmune disease discuss AHN's Autoimmunity Institute joining forces with the Relapsing Polychondritis Foundation.